Replies to post #1712 on Galectin Therapeutics Inc (GALT)

[thefamilyman]

My best guess... Two things:
1) Not disclosing the change in protocol for Cohort 2 in a timely manner created a serious lack of confidence in this management team. And the poor wording of the initial announcement of the Phase 2 certainly did nothing to overcome that concern.
2) This drug has already been approved for Fast Track, yet the Phase 2 is not expected to start until the 2nd quarter of 2015. That means Phase 2 results are probably 12 to 18 months out.

In a nutshell, I think the actual Cohort 3 results are worthy of a much higher share price. In fact, without that change in protocol for Cohort 2, I believe we would currently be at $30+ per share. But the lack of confidence that resulted from management's mishandling of Cohort 2 is proving hard to shake. And now it will apparently be a while before Phase 2 results can put all that behind us. So the only thing we can do now is wait...

This price collapse in GALT...from 19 down to 4 dollars has become shocking to me.
what do you fundamentalist think of this collapse? what are the Fundamental company reasons why this has happened?? - 123tom